- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Profitable Climbers
Hong Kong Pharmaceuticals & Biotech Profitable Climbers
Results
10
10 companies
WuXi XDC Cayman
Market Cap: HK$66.6b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$52.95
7D
-2.1%
1Y
24.0%
Biocytogen Pharmaceuticals (Beijing)
Market Cap: HK$35.3b
A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.
2315
HK$51.80
7D
-4.5%
1Y
228.7%
RemeGen
Market Cap: HK$65.8b
A biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States.
9995
HK$93.20
7D
5.0%
1Y
370.2%
CanSino Biologics
Market Cap: HK$13.7b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$33.16
7D
-0.9%
1Y
-2.6%
Consun Pharmaceutical Group
Market Cap: HK$13.7b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$16.27
7D
-5.8%
1Y
86.4%
JBM (Healthcare)
Market Cap: HK$2.2b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.65
7D
-4.0%
1Y
47.2%
Innovent Biologics
Market Cap: HK$140.6b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.
1801
HK$81.05
7D
0.2%
1Y
99.6%
Luye Pharma Group
Market Cap: HK$9.4b
Develops, produces, markets, and sells pharmaceutical products in the People’s Republic of China, the United States, Europe, and internationally.
2186
HK$2.36
7D
-2.9%
1Y
0.9%
China Medical System Holdings
Market Cap: HK$32.7b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$13.49
7D
6.1%
1Y
76.3%
Simcere Pharmaceutical Group
Market Cap: HK$29.8b
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.
2096
HK$11.52
7D
-0.09%
1Y
47.9%